Evaxion A (EVAX) Assets Average (2021 - 2026)
Evaxion A (EVAX) reported Assets Average of $26.0 million for Q1 2026, up 37.98% on a YoY basis from $18.9 million in Q1 2025, and down 10.48% quarter-over-quarter from $29.1 million in Q4 2025.
Evaxion A (EVAX) Assets Average (2021 - 2026) Analysis & Trends
Evaxion A has reported Assets Average for 6 years, with the latest figure at $26.0 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 37.98% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $26.0 million (up 37.98% YoY), and the FY2025 full-year result was $20.4 million, up 61.16% from the prior year.
- Assets Average for Q1 2026 stood at $26.0 million, down from $29.1 million in the prior quarter.
- The five-year high for Assets Average was $40.6 million in Q1 2022, with the low at $6.5 million in Q1 2024.
- Historically, Assets Average has averaged $22.5 million across 5 years, with a median of $23.8 million in 2025.
- Annual changes were most pronounced in 2024 — Assets Average tumbled 69.63% — and 2025, when it surged 212.63%.
- Evaxion A's Assets Average stood at $24.7 million in 2022, then slumped by 49.81% to $12.4 million in 2023, then tumbled by 38.57% to $7.6 million in 2024, then soared by 281.19% to $29.1 million in 2025, then retreated by 10.48% to $26.0 million in 2026.
- The last three Assets Average figures came in at $26.0 million (Q1 2026), $29.1 million (Q4 2025), and $26.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 40.71 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.03 Mn |
| Dec 31, 2025 | 29.07 Mn |
| Sep 30, 2025 | 26.09 Mn |
| Jun 30, 2025 | 23.84 Mn |
| Mar 31, 2025 | 18.86 Mn |
| Jun 30, 2024 | 7.63 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Dec 31, 2023 | 12.42 Mn |
| Sep 30, 2023 | 14.35 Mn |
| Jun 30, 2023 | 18.62 Mn |
| Mar 31, 2023 | 21.26 Mn |
| Dec 31, 2022 | 24.74 Mn |
| Sep 30, 2022 | 30.73 Mn |
| Jun 30, 2022 | 37.54 Mn |
| Mar 31, 2022 | 40.62 Mn |
| Dec 31, 2021 | 32.14 Mn |
| Sep 30, 2021 | 25.89 Mn |
| Jun 30, 2021 | 31.29 Mn |
| Mar 31, 2021 | 23.44 Mn |